secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001601485-24-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio raises $6.0M via pre-funded warrants sale to board-member entity GKCC, LLC
--------------------------------------------------------------------------------

- Private placement of pre-funded warrants for 1,032,702 shares at $5.81 each; gross proceeds ~$6.0M.
- Warrants exercisable at $0.01/share subject to 19.99% beneficial ownership cap unless stockholder approval obtained.
- Purchaser GKCC, LLC is controlled by a member of Elicio's board of directors.
- Closing expected March 19, 2024; proceeds for pipeline advancement and working capital.
- Company must file resale registration statement with SEC by June 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000015/0001601485-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148524000015/angn-20240318.htm
  HTML page:      https://secwatch.observer/filing/0001601485-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer